MAIN RESULTS:
Efficacy and safety of evolocumab in reducing lipids and cardiovascular events
PRESENTATIONS
OSLER Outcomes (Sabatine ACC 2015)
An Academic Research Organization of Brigham & Women's Hospital and An Affiliate of Harvard Medical School
